Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation

Targeting the function of epidermal growth factor receptor (EGFR) has failed as an effective clinical option for breast cancer. Understanding the drivers of inherent resistance has been a challenge. One possible mechanism is the acquisition of stem-like properties through the process of epithelial-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Wells S, Wendt, Michael K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728772/
https://www.ncbi.nlm.nih.gov/pubmed/25255930
http://dx.doi.org/10.1186/s13058-014-0448-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728772/
https://www.ncbi.nlm.nih.gov/pubmed/25255930
http://dx.doi.org/10.1186/s13058-014-0448-0

Ejemplares similares